Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

248
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
248
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

520
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
520
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

324
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
324
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug01:14

Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug

278
In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
278
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

201
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
201
Clinical Trials01:16

Clinical Trials

11.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
11.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Critical Appraisal of Self-Supervised Contrastive Pretraining for Extreme Few-Shot ECG Classification.

Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc·2026
Same author

Hemodynamic Assessment in Newborn Infants With Sepsis: A Prospective Observational Study.

Cureus·2026
Same author

Risk Factors Associated With Febrile Seizures in Young Children: Clinical, Biochemical, and Genetic Perspectives.

Cureus·2026
Same author

The Transitional Liver Clinic: Study protocol for a stepped-wedge cluster randomized trial.

Hepatology communications·2026
Same author

Optimized cumate toolkit for tunable protein expression during <i>in vitro</i> and <i>in vivo</i> studies of <i>Burkholderia cenocepacia</i>.

Applied and environmental microbiology·2026
Same author

Caregiver Involvement and Burden and Patient Quality of Life in Patients with Decompensated Cirrhosis.

The American journal of gastroenterology·2026

Related Experiment Video

Updated: Mar 19, 2026

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro
11:06

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro

Published on: January 31, 2022

5.5K

Implementation science: a primer for hepatology research.

Manisha Verma1, Hamza Tahir, Richard Kalman

  • 1Department of Medicine, Jefferson Einstein Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.

Current Opinion in Gastroenterology
|March 17, 2026
PubMed
Summary
This summary is machine-generated.

Implementation science bridges the gap between hepatology research and patient care. It addresses challenges in adopting evidence-based interventions to improve liver disease outcomes and ensure equitable care delivery.

Keywords:
healthcare deliveryhepatologyimplementation outcomesimplementation scienceliver diseases

More Related Videos

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

6.3K
Author Spotlight: Investigating Hepatic Adaptations and Prediabetic Progression in Liver Diseases
06:21

Author Spotlight: Investigating Hepatic Adaptations and Prediabetic Progression in Liver Diseases

Published on: October 6, 2023

2.8K

Related Experiment Videos

Last Updated: Mar 19, 2026

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro
11:06

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro

Published on: January 31, 2022

5.5K
A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

6.3K
Author Spotlight: Investigating Hepatic Adaptations and Prediabetic Progression in Liver Diseases
06:21

Author Spotlight: Investigating Hepatic Adaptations and Prediabetic Progression in Liver Diseases

Published on: October 6, 2023

2.8K

Area of Science:

  • Hepatology
  • Implementation Science
  • Health Services Research

Background:

  • Hepatology faces challenges in translating evidence-based interventions into routine practice.
  • Variability in adoption leads to gaps in care quality, outcomes, and equity.
  • Implementation science provides systematic approaches to improve intervention delivery and sustainability.

Purpose of the Study:

  • To provide an overview of implementation science in hepatology.
  • To discuss the importance of implementation science for advancing hepatology research and practice.

Main Methods:

  • Review of recent studies applying implementation science frameworks in hepatology.
  • Focus on understanding barriers to intervention adoption and strategies for overcoming them.
  • Common use of established frameworks, pragmatic trial designs, and mixed methods.

Main Results:

  • Implementation science frameworks have been applied to viral hepatitis elimination, cirrhosis management, palliative care, hepatocellular cancer surveillance, and alcohol use disorder treatment.
  • Studies highlight the importance of context, stakeholder engagement, and strategy selection.
  • Outcomes assessed include adoption, fidelity, sustainability, and clinical impact.

Conclusions:

  • Implementation science serves as a practical bridge between discovery and routine hepatology care.
  • Integrating implementation principles accelerates evidence translation and reduces care variation.
  • This approach promotes more equitable delivery of liver-related services.